Sunday, November 18, 2012

As Stryker Hip Recall Lawsuits Mount, Company Taps Former DePuy Orthopaedics CEO to Head Up Ortho Division

Equities.com
 
Stryker hip recall lawsuits prompted by the company’s recent recall of Rejuvenate and ABG II Modular Hip Stems continue to mount, as Stryker announces that David Floyd, former CEO of DePuy Orthopeadics, will now head up its orthopedics unit, Bernstein Liebhard LLP reports. The company is facing at least 10 Stryker Rejuvenate lawsuits in New Jersey Superior Court, and plaintiffs have requested that all such claims filed in the state be assigned to Judge Brian Martinotti in Bergen County.* According to a report from MassDevice.com, Floyd left DePuy Orthopaedics in March, amid the fallout over the August 2010 DePuy ASR hip implant recall.**

“We expect that those impacted by this recall will continue to file Stryker Rejuvenate lawsuits in New Jersey and elsewhere, adding to the challenges Mr. Floyd will face in his new position,” says Bernstein Liebhard LLP, a nationwide law firm representing the victims of defective drugs and medical devices. The firm is currently offering free legal evaluations to anyone affected by the recent Stryker hip recall.

Stryker Rejuvenate Recall On July 6, 2012, Stryker issued a recall of its Stryker Rejuvenate and ABG II Modular Hip Stems due to a potential for fretting and corrosion at the modular-neck junction. According to the Stryker hip recall notice, patients with the Rejuvenate or AGB II hip implant components may develop adverse local tissue reactions that could manifest with symptoms of pain and/or swelling. Some 20,000 of the affected implants had been sold prior to the Stryker hip recall, the company said.***
 
"David brings a strong medical device and orthopedic perspective to Stryker through his successful leadership roles in a broad range of enterprises, including a venture backed startup, middle market med tech and large cap multinationals. He is a proven leader who has demonstrated the ability to drive profitable growth through innovation and we are delighted to have David join our executive team at Stryker. Mr Floyd has successfully managed global businesses through unprecedented industry change while maintaining strong company, regulatory and customer relationships," said Mr Lobo

No comments:

Post a Comment